Kimera Labs Named Semifinalist in XPRIZE Healthspan Competition

Kimera Labs named semifinalist in XPRIZE Healthspan competition

We are incredibly proud to share a major advancement from our trusted lab partner, Kimera Labs. Of over 600 teams worldwide, Kimera has officially been named a top 40 semifinalist in the $101 million XPRIZE Healthspan competition, an international challenge designed to revolutionize healthy aging and extend the human healthspan.

The XPRIZE Healthspan competition is one of the largest initiatives in the world focused on delaying age-related decline and improving quality of life as we grow older. Kimera's selection as a semifinalist highlights their pioneering work in exosome technology — small, cell-derived vesicles that play a powerful role in cellular communication, tissue repair, and inflammation regulation.

At our clinic, we proudly utilize exosomes from Kimera’s cutting-edge lab, offering patients access to some of the most advanced regenerative therapies available today.

This recognition further confirms what we've already seen firsthand: exosome-based therapies are transforming the way we approach healing, longevity, and chronic conditions — naturally and without invasive procedures.

We are proud to work closely with a lab at the forefront of science and committed to helping patients experience meaningful improvements in pain, function, and overall health.

Whether you're seeking relief from joint pain, injury, or a chronic condition, the future of healing is here — and already available.

Read the full press release here.